Advisory Board
Dr. Barry D. Pressman MD, FACR | Chair – Medical Advisory Board
Dr. Pressman is Professor and Chairman of the S. Mark Taper Foundation Imaging Center and Department, and Chief of the Section of Neuroradiology and Head and Neck Radiology at Cedars-Sinai Medical Center, located in Los Angeles, Ca.
Dr. Pressman is a past President of The American College of Radiology, the Western Neuroradiological Society, as well as past President of the California Radiological Society. Currently he is a member of the American Society of Neuroradiology and the American Society of Pediatric Neuroradiology.
Dr. Pressman earned his medical degree Cum Laude from Harvard Medical School after graduating Summa Cum Laude from Dartmouth College. After a surgical internship at Harvard's Peter Bent Brigham Hospital in Boston, he completed a diagnostic radiology residency at Columbia-Presbyterian Medical Center in New York and a Neuroradiology fellowship at George Washington University Hospital. During this period, he wrote many original papers for Computer Tomography(CT).
"I am delighted to Chair the Medical Advisory Board (MAB) for Vivos. I anticipate expansion of our MAB, initially focusing on the potential for the Company's brachytherapy products," said Pressman.
Dr. Albert S. DeNittis MD, MS, FCPP | Medical Advisory Board.
Dr. Albert S. DeNittis is currently is the Chief of Radiation Oncology at Lankenau Medical Center and Clinical Professor at Lankenau Insitute for Medical Research
in Wynnewood, Pennsylvania and the Director of Radiation Oncology at Brodesseur Cancer Center in New Jersey. He is also the Principal Investigator and in charge of a grant awarded by the NIH for
its National Cancer Oncology Research Program (NCORP) at Main Line Health. Dr. DeNittis practice experience includes image-guided radiosurgery, stereotactic body radiation therapy (SBRT),
intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), high-dose rate (HDR) brachytherapy, cranial and extracranial stereotactic radiosurgery, respiratory gating,
and Cyberknife.
Dr. DeNittis has served on numerous regional, national and government committees related to key issues in the field of oncology including the NRG Oncology group
which focuses on protocol development for cancer patients on the national level. He has received regional and national awards for his research and his clinical work and authored over 100
publications and presentations as well as 6 book chapters. He has. Dr. DeNittis previously has been awarded a number of grants to study the impact of various novel oncology drugs and radiation
protocols. He is a long standing member of key professional societies including the American Society of Radiation Oncology, the American Society of Clinical Oncology, and American Brachytherapy
Society. Dr. DeNittis is a cofounder and board member of DermRad Therapy which is developing a multidisciplinary approach to skin cancer treatment.
Dr. DeNittis earned a BA and a MS at Rutgers University and a MD from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New
Jersey. He completed postdoctoral training internships and residency at the Department of Radiation Oncology at the Hospital of the University of Pennsylvania. Dr. DeNittis is board certified by
the American Board of Radiology and Licensed in New Jersey and Pennsylvania.
Dr. Alice Villalobos, DVM, FNAP | Chair – Veterinary MedicAL Advisory Board
Dr. Alice Villalobos is a well known pioneer in the field of cancer care for companion animals and a founding member of the Veterinary Cancer Society. A 1972 graduate of UC Davis, she completed Dr. Gordon Theilen’s first mock residency program in oncology and has served the profession by consulting, writing and lecturing in the rapidly growing field of veterinary oncology and end of life care.
Dr. Alice Villalobos is President Emeritus of the Society for Veterinary Medical Ethics, Past President of the American Association of Human Animal Bond Veterinarians and Chair of the Veterinary Academy for the National Academies of Practice. She operated Coast Pet Clinic/Animal Cancer Center for 25 years, which is now VCA Coast Animal Hospital. She is the author of numerous articles, papers, and including her classic veterinarian textbook, Canine and Feline Geriatric Oncology: Honoring the Human-Animal Bond. She has lectured worldwide on oncology, quality of life, the human-animal bond and end of life care and bioethics. She founded Pawspice, an end of life care program that embraces kinder, gentler palliative cancer medicine and integrative care for pets with cancer and terminal illness (www.Pawspice.com). Dr. Alice is Director of Animal Oncology Consultation Service in Woodland Hill, California and Pawspice at VCA Coast Animal Hospital in Hermosa Beach, California. Dr. Alice was elected 2016 Hermosa Beach Woman of the Year.
Dr. Alice’s role with Vivos Inc. is to support the commercialization of the Company’s yttrium-90 brachytherapy IsoPet® products for use in companion animals.
- President Emeritus, Society for Veterinary Medical Ethics
- Fellow Emeritus, National Academies of Practice
- Past President, American Association of Human-Animal Bond Veterinarians
- International Association of Animal Hospice and Palliative Care
- Director, Pawspice & Animal Oncology Consultation Service
- Founder, Peter Zippi Memorial Fund for Animals
- Consultant, Oregon Tiger Rescue & Pacific Marine Mammal Center, Laguna Bch.
- Board of Directors, Animal Health Foundation
Tariq Shah, BSc. DipMS (DIRECTOR • ONCOLOGIZE™) | Veterinary Medical Advisory Board
Tariq Shah has been working within Animal Health for 25 years. A graduate in Marine Biology from the University of Liverpool, United Kingdom, he has held managerial positions for both veterinary pharmaceutical companies and veterinary diagnostic laboratories. He completed his management diploma in 2000. In addition to his early research in marine physiology, he has more recently worked for 2 years in biotech in the early stage development of novel treatments for cancer-induced cachexia.
Since he came to the US in 2008, he has worked with veterinary oncologists across America, conducting research and commercializing diagnostic
technology. He holds an adjunct faculty position at the University of Missouri College of Veterinary Medicine.
In 2017 he established Oncologize, a pioneering company designed to support and assist organizations in their development and
commercialization of oncology products, and is extremely happy to be supporting IsoPet® in this
exciting venture.
- Adjunct Faculty
- University of Missouri
- Department of Veterinary Medicine and Surgery